Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
clofazimine | Capsule | 100 mg | |
dapsone | Tablet | 100 mg | |
rifampicin | Oral liquid | 100mg/5ml | |
rifampicin | Solid oral dosage form | 300 mg | |
thalidomide | Tablet | 100 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ethambutol | Tablet | 400mg (chlorohydrate) | |
isoniazid | Tablet | 100mg | |
isoniazid | Tablet | 300mg | |
isoniazid + rifampicin | Tablet | 150 mg + 300 mg | |
pyrazinamide | Tablet | 500 mg | |
streptomycin | Injection | 1g (sulfate) | |
thioacetazone + isoniazid | Tablet | 150mg + 300mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chloroquine | Injection | 420mg (as phosphate for sulfate)/5ml | |
chloroquine | Injection | 60mg (as phosphate for sulfate)/2ml | |
chloroquine | Oral liquid | 25mg (as phosphate for sulfate)/5ml | |
chloroquine | Tablet | 150 mg (as phosphate or sulfate) | |
mefloquine | Tablet | 250 mg | |
primaquine | Tablet | 15 mg (phosphate) | |
pyrimethamine | Tablet | 25 mg | |
quinine | Capsule | 200mg (sulfate) | |
quinine | Capsule | 600mg (sulfate) | |
quinine | Injection | 100mg (dihydrochloride)/2ml | |
quinine | Tablet | 300 mg (quinine sulfate) | |
sulfadoxine + pyrimethamine | Oral liquid | (500mg + 25mg)/5ml | |
sulfadoxine + pyrimethamine | Tablet | 500 mg + 25 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
meglumine antimoniate | Injection | 1.5g/5ml | |
nifurtimox | Tablet | 120 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
oral rehydration salts | Powder for dilution | according to standard concentrations |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
sodium fluoride | Gel | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
BCG vaccine | N/A | N/A | |
diphtheria, tetanus toxoid | Injection | N/A | |
DTP vaccine | Injection | diphtheria, tetanus, pertussis | |
Haemophilus influenzae type b vaccine (Hib vaccine) | N/A | N/A | |
hepatitis B vaccine | N/A | N/A | |
measles vaccine | N/A | N/A | |
mumps vaccine | N/A | N/A | |
poliomyelitis vaccine | Oral liquid | N/A | |
rabies vaccine | N/A | N/A | |
rubella vaccine | N/A | N/A | |
tetanus toxoid | Injection | N/A | |
yellow fever vaccine | N/A | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
anti rabies human serum | Injection | according to availability | |
diphtheria antitoxin | Injection | N/A | |
monovalent anti snake venom serum | Injection | N/A | |
polyvalent anti snake venom serum | Injection | N/A | |
tetanus antitoxin | Injection | according to availability |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
allopurinol | Tablet | 100 mg | |
allopurinol | Tablet | 300 mg | |
colchincine | Tablet | 0.5mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chlorphenamine | Oral liquid | 2mg/5ml | |
chlorphenamine | Tablet | 4 mg (hydrogen maleate) | |
diphenhydramine | Capsule | 50 mg | |
diphenhydramine | Injection | 100 mg/10 mL | |
diphenhydramine | Oral liquid | 12.5 mg/5 mL | |
loratadine | Oral liquid | 5 mg/mL | |
loratadine | Tablet | 10 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amoxicillin | Capsule | 250 mg | |
amoxicillin | Capsule | 500 mg | |
amoxicillin | Oral liquid | 250 mg/5 mL | |
ampicillin | Oral liquid | 125 mg/5 mL (anhydrate or trihydrate) | |
ampicillin | Oral liquid | 250 mg/5 mL (anhydrate or trihydrate) | |
ampicillin | Powder for injection | 1 g (as sodium salt) in vial | |
ampicillin | Powder for injection | 500 mg (as sodium salt) in vial | |
ampicillin | Tablet | 250 mg (anhydrate or trihydrate) | |
ampicillin | Tablet | 500 mg (anhydrate or trihydrate) | |
benzathine benzylpenicillin | Injection | 1 200 000 IU | |
benzathine benzylpenicillin | Injection | 2 400 000 IU | |
cefadroxil | Oral liquid | 250mg/5ml | |
cefalexin | Oral liquid | 125 mg/5 mL | |
cefalexin | Tablet | 250 mg | |
cefalexin | Tablet | 500 mg | |
cefalotine | Powder for reconstitution with water | 1g | |
cefazolin | Injection | 1g | |
cefradine | Powder for reconstitution with water | 1g | |
cefradine | Solid oral dosage form | 500mg | |
chloramphenicol | Capsule | 250 mg | |
chloramphenicol | Oral liquid | 125 mg (stearate or palmitate)/5 mL | |
ciprofloxacin | Tablet | 250 mg (as hydrochloride) | |
ciprofloxacin | Tablet | 500mg (hydrochloride) | |
dicloxacillin | Oral liquid | 250mg/5ml | |
dicloxacillin | Suspension | 125mg/5ml | |
dicloxacillin | Tablet | 250mg | |
dicloxacillin | Tablet | 500mg | |
doxycycline | Tablet | 100mg | |
erythromycin | Suspension | 250 mg (ethysuccinate)/5 mL | |
erythromycin | Tablet | 500 mg (as ethylsuccinate) | |
furazolidone | Oral liquid | 50mg/15ml | |
furazolidone | Tablet | 100mg | |
gentamicin | Injection | 160 mg (sulfate)/2 mL | |
gentamicin | Injection | 20 mg (sulfate)/2 mL | |
gentamicin | Injection | 40 mg (sulfate)/ml in 2-mL vial | |
gentamicin | Injection | 80 mg (sulfate)/2 mL | |
nitrofurantoin | Tablet | 100 mg | |
nitrofurantoin | Tablet | 50mg | |
norfloxacin | Tablet | 400 mg | |
phenoxymethylpenicillin | Powder for oral liquid | 250 mg (as potassium salt)/5 ml | |
phenoxymethylpenicillin | Tablet | 500 to 650mg | |
procaine benzylpenicillin | Injection | 400,000 IU | |
procaine benzylpenicillin | Injection | 800,000 IU | |
sodium benzylpenicillin | Injection | 1,000,000 IU | |
sodium benzylpenicillin | Injection | 5,000,000 IU | |
spiramycin | Tablet | 3 million IU for exclusively toxoplasmosis | |
sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg | |
sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg | |
tetracycline | Capsule | 500 mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
fluconazole | Capsule | 200 mg | |
fluconazole | Oral liquid | 1%-4% | |
ketoconazole | Suspension | 100 mg/5mL | |
ketoconazole | Tablet | 200 mg | |
nystatin | Oral liquid | 100 000 IU/ml | |
nystatin | Tablet | 500 000 IU |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
diiodohydroxyquinoline | Tablet | 650mg | |
metronidazole | Oral liquid | 125 mg (benzoate)/5 mL | |
metronidazole | Oral liquid | 250 mg (benzoate)/5 mL | |
metronidazole | Tablet | 250 mg | |
metronidazole | Tablet | 500 mg | |
teclozan | Tablet | 500mg | |
tinidazole | Oral liquid | 1 g/5 mL | |
tinidazole | Tablet | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
albendazole | Oral liquid | 100mg/5ml | |
albendazole | Tablet | 200mg | |
mebendazole | Suspension | 100mg/5ml | |
mebendazole | Tablet (chewable) | 100 mg | |
niclosamide | Tablet (chewable) | 500 mg | |
piperazine | Oral liquid | 1g/5 mL | |
praziquantel | Tablet | 150 mg | |
pyrantel | Oral liquid | 250mg (embonate or pamoate)/5ml | |
pyrantel | Tablet (chewable) | 250 mg (as embonate or pamoate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
diclofenac | Injection | 75 mg/3 mL | |
diclofenac | Tablet | 50 mg | |
gold thioglucose | Injection | 500mg/10ml (exclusive use by specialists) | |
ibuprofen | Tablet | 400 mg | |
naproxen | Oral liquid | 150mg/5 mL | |
naproxen | Tablet | 250 mg (sodium) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
isosorbide dinitrate | Tablet | 10 mg | |
isosorbide dinitrate | Tablet | 40 mg | |
isosorbide dinitrate | Tablet (sublingual) | 5 mg | |
verapamil | Tablet | 120 mg (hydrochloride) | |
verapamil | Tablet | 80 mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amiodarone | Tablet (HCI) | 200 mg (hydrochloride) | |
quinidine | Tablet | 200 mg (sulfate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
captopril | Tablet | 25 mg | |
captopril | Tablet | 50 mg | |
enalapril | Tablet | 20 mg (maleate) | |
enalapril | Tablet | 5 mg (as hydrogen maleate) | |
hydralazine | Tablet | 25 mg (hydrochloride) | |
methyldopa | Tablet | 250 mg | |
metoprolol | Tablet | 100mg (tartrate) | |
metoprolol | Tablet | 50mg (tartrate) | |
nifedipine | Tablet (prolonged release) | 30mg | |
prazosin | Tablet | 1mg | |
propranolol | Tablet | 40 mg (hydrochloride) | |
propranolol | Tablet | 80mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
furosemide | Injection | 20 mg/2 mL | |
furosemide | Tablet | 40 mg | |
hydrochlorothiazide | Solid oral dosage form | 25 mg | |
spironolactone | Tablet | 100mg | |
spironolactone | Tablet | 25 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dihydroergotoxine | Tablet | 4.5mg (mesylate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
corticoid + anesthetic | Cream | according to availability | |
corticoid + anesthetic | Suppository | according to availability |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aluminum and magnesium hydroxide | Oral liquid | 2-6% + 1-4% | |
aluminum and magnesium hydroxide | Tablet | 200-400mg + 200-400mg | |
aluminum hydroxide gel | Oral liquid | 6% | |
aluminum hydroxide gel | Tablet | 234mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
calcium carbonate | Tablet | 600 mg | |
sodium fluoride | Tablet | 40mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
metoclopramide | Injection | 10 mg (hydrochloride)/2 mL | |
metoclopramide | Oral liquid | 4 mg (hydrochloride)/mL | |
metoclopramide | Tablet | 10 mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
hyoscine hydrobromide | Injection | 0.02 g + 2.5 g dipyrone in 5mL | |
hyoscine hydrobromide | Injection | 20 mg/mL | |
hyoscine hydrobromide | Tablet | 10 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
omeprazole | Solid oral dosage form | 20 mg | |
ranitidine | Injection | 50 mg (hydrochloride)/2 mL | |
ranitidine | Tablet | 150 mg (hydrochloride) | |
ranitidine | Tablet | 300mg (hydrochloride) | |
sucralfate | Tablet | 1 g |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
loperamide | Solid oral dosage form | 2mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
mesalazine | Enema | 4 g | |
mesalazine | Suppository | 500 mg | |
mesalazine | Tablet (enteric-coated) | 500 mg | |
sulfasalazine | Tablet | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
glibenclamide | Tablet | 5 mg | |
metformin | Tablet | 850 mg | |
NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL | |
tolbutamide | Tablet | 500 mg | |
zinc crystalline insulin | Injection | 100 IU/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cholestyramine | Granules | 4 g | |
gemfibrozil | Tablet | 600mg | |
lovastatin | Tablet | 20mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
potassium gluconate | Oral liquid | 31.2% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
bromocryptin | Tablet | 2.5mg | |
danazol | Capsule | 200 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
testosterone | Injection | 250 mg (ester)/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
betamethasone | Injection | 3 mg (phosphate) + 3 mg (acetate) per mL | |
betamethasone | Injection | 4 mg (sodium phosphate)/mL | |
dexamethasone | Injection | 4 mg (phosphate)/mL | |
dexamethasone | Injection | 8 mg (acetate)/mL | |
prednisone | Tablet | 5 mg | |
prednisone | Tablet | 50 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
conjugated estrogens | Tablet | 0.625 mg | |
conjugated estrogens | Tablet | 1.25 mg | |
estradiol | Tablet | 2 mg (valerate) or 25-50 mcg/day transdermally |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
hydroxyprogesterone | Injection | 250 mg/mL | |
medroxyprogesterone acetate | Injection | 50 mg/mL | |
medroxyprogesterone acetate | Tablet | 5 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
levothyroxine | Tablet | 100 mcg (sodium salt) | |
levothyroxine | Tablet | 50 mcg (sodium salt) | |
levothyroxine + liothyronine | Tablet | 120 mcg + 30 mcg | |
liothyronine | Tablet | 25mcg | |
methimazole | Tablet | 5 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
vasopressin | Injection | 5 IU/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ergometrine | Tablet | 200 mcg (maleate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cromoglycate | Nasal spray | 20 mg (sodium)/ml | |
cromoglycate | Nasal spray | 40 mg (sodium)/ml | |
oxymethazoline | Nasal spray | 0.25 mg/ml | |
oxymethazoline | Nasal spray | 0.5 mg/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
colistine + corticoid + neomycin | Ear drops | 0.15% + 0.05% + 0.5% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
proxymetacaine | Solution (eye drops) | 0.5% | |
tetracaine | Solution (eye drops) | 0.5% (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chloramphenicol | Eye ointment | 1% | |
chloramphenicol | Solution (eye drops) | 0.5% | |
gentamicin | Eye ointment | 3 mg (sulfate)/mL | |
gentamicin | Solution (eye drops) | 0.3% (sulfate) | |
neomycin + polymixin B | Solution (eye drops) | 0.3-0.5% (sulfate) + 5000-20000 IU/ml | |
sulfacetamide | Solution (eye drops) | 10% | |
sulfacetamide | Solution (eye drops) | 30% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aciclovir | Ointment | 3% W/W | |
idoxuridine | Solution (eye drops) | 1 mg/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
corticoid | Solution (eye drops) | 0.1 - 1% | |
corticoid + neomycin + polymixin | Solution (eye drops) | 0.1% + 0.35% + 6000 IU/ml | |
fluorometholone | Solution (eye drops) | 0.1% | |
prednisolone + phenylephrine | Solution (eye drops) | 1% + 0.12% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
atropine | Solution (eye drops) | 0.5% (sulfate) | |
atropine | Solution (eye drops) | 1% (sulfate) | |
tropicamide | Solution (eye drops) | 1% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
pilocarpine | Solution (eye drops) | 2% (hydrochloride or nitrate) | |
pilocarpine | Solution (eye drops) | 4% (hydrochloride or nitrate) | |
pilocarpine | Solution (eye drops) | 4% (hydrochloride or nitrate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetazolamide | Tablet | 250 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cromoglycate | Solution (eye drops) | 2% (sodium) | |
cromoglycate | Solution (eye drops) | 4& (sodium) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
barium sulfate | Oral liquid | N/A | |
fluorescein | Solution (eye drops) | 2% | |
iohexol | Injection | 180 mg of iodine/ml | |
ioversol | Injection | 320 | |
meglumine diatrizoate | Injection | 60% | |
meglumine diatrizoate | Injection | 66% + 10% sodium diatrizoate | |
meglumine diatrizoate | Oral liquid | 66% + 10% sodium diatrizoate | |
meglumine iodamide | Injection | 26% | |
meglumine iodamide | Injection | 65% | |
meglumine iodothalamate | Injection | 60% | |
sodium iopodate | Capsule | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
clotrimazole | Vaginal cream | 1% | |
clotrimazole | Vaginal tablet | 100 mg | |
conjugated estrogens | Vaginal cream | 0.625 mg | |
metronidazole | Suppository | 500 mg | |
nystatin | Pessary | 100 000 IU |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
clotrimazole | Cream | 1% | |
clotrimazole | Solution | 1% | |
nystatin | Cream | 100 000 IU/g |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
benzyl benzoate | Lotion | 25% | |
crotamiton | Cream | 10% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
iodine-povidone | Solution | 10% | |
silver sulfadiazine | Cream | 1% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
betamethasone | Cream | 0.05% | |
betamethasone | Ointment | 0.05% | |
corticoid, fluorinated | Topical | N/A | |
hydrocortisone | Cream | 1% (acetate) | |
hydrocortisone | Lotion | 0.5% (acetate) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
coal tar | Lotion | 5% + 2% allantoin | |
retinoic acid | Cream | 0.05% | |
retinoic acid | Lotion | 0.05% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aluminum acetate | Powder | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
methoxsalen | Tablet | 10mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
fluorouracil | Ointment | 5% | |
podophyllum resin | Topical | 20% | |
Unna's paste | Paste | magistral preparation |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dihydrocodeine | Oral liquid | 13.6 mg (bitartrate)/ml | |
dihydrocodeine | Oral liquid | 2.42 mg (bitartrate)/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
aminophylline | Tablet | 100 mg | |
ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
salbutamol | Inhalation (aerosol) | 100 mcg (as sulfate) per dose | |
salbutamol | Injection | 0.5 mg/mL | |
salbutamol | Oral liquid | 2 mg/5 mL | |
salbutamol | Respirator solution for use in nebulizers | 0.5% | |
salbutamol | Tablet | 2 mg | |
salbutamol | Tablet | 4 mg | |
terbutaline | Injection | 0.5 mg (sulfate)/ml | |
terbutaline | Respirator solution for use in nebulizers | 1% (sulfate) | |
terbutaline | Tablet | 1.5 mg (sulfate)/5ml (0.03%) | |
terbutaline | Tablet | 2.5mg (sulfate) | |
theophylline | Oral liquid | 80 mg/5 mL | |
theophylline | Tablet (prolonged release) | 125 mg | |
theophylline | Tablet (prolonged release) | 300 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
beclometasone | Inhalation (aerosol) | 250 micrograms (dipropionate) per dose | |
beclometasone | Metered dose inhaler (aerosol) | 50 micrograms (dipropionate) per dose | |
cromoglycate | Inhalation | 5 mg (sodium)/dose | |
ketotifen | Oral liquid | 1 mg/5 mL (0.02%) | |
ketotifen | Tablet | 1 mg | |
oxygen | Inhalation (medicine gas) | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
folic acid | Tablet | 1 mg | |
hydroxocobalamin | Injection | 1 mg/mL | |
iron | Oral liquid | 25 mg (sulfate)/ml | |
iron | Parenteral formulation | minimum of 20 mg of iron/ml solution | |
iron | Tablet | 100-300 mg (anhydride sulfate) | |
vitamin B12 | Injection | 1 mg/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
warfarin | Tablet | 5 mg (sodium salt) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylsalicylic acid | Solid oral dosage form | 300-400 mg + up to 35 mg codeine or up to 10 mg oxycodone | |
codeine | Tablet | 30 mg (phosphate) | |
codeine | Tablet | 60mg (phosphate) | |
morphine | Oral liquid | 30 mg/mL (3%) | |
morphine | Solid oral dosage form | 30 mg (sulfate) | |
morphine | Solid oral dosage form | 60 mg (sulfate) | |
morphine | Tablet (prolonged release) | 100 mg (morphine sulfate) | |
oxycodone | Tablet (prolonged release) | 10 mg | |
oxycodone | Tablet (prolonged release) | 20 mg | |
oxycodone | Tablet (prolonged release) | 40 mg | |
tramadol | Oral liquid | 100 mg (hydrochloride)/mL (as drops) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
methocarbamol | Tablet | 750 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
alprazolam | Tablet | 0.25 mg | |
alprazolam | Tablet | 500 mcg | |
diazepam | Oral liquid | 2 mg/mL (0.4%) | |
diazepam | Tablet | 10 mg | |
diazepam | Tablet | 5 mg | |
lorazepam | Tablet | 1-2mg | |
midazolam | Tablet | 7.5 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
pyridostigmine | Tablet | 60 mg (bromide) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dimenhydrinate | Tablet | 50 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
methylphenidate | Tablet | 10 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
nimodipine | Capsule | 30 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylsalicylic acid | Tablet | 100 mg | |
acetylsalicylic acid | Tablet | 500 mg | |
paracetamol | Oral liquid | 100 mg/ml | |
paracetamol | Oral liquid | 140 mg/5 ml (3%) | |
paracetamol | Tablet | 500 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
lidocaine | Dental cartridge | 2% (hydrochloride) | |
lidocaine | Injection | 1% (hydrochloride) in vial | |
lidocaine | Injection | 2% (hydrochloride) in vial | |
lidocaine + epinephrine (adrenaline) | Dental cartridge | 2% (hydrochloride) + epinephrine 1:80 000 | |
lidocaine + epinephrine (adrenaline) | Injection | 1% (hydrochloride or sulfate) + epinephrine 1:200 000 in vial | |
lidocaine + epinephrine (adrenaline) | Injection | 2% (hydrochloride or sulfate) + epinephrine 1:200 000 in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
carbamazepine | Oral liquid | 100 mg/5 ml | |
carbamazepine | Tablet | 200 mg | |
clonazepam | Oral liquid | 2.5 mg/ml | |
clonazepam | Tablet | 2mg | |
clonazepam | Tablet | 500mcg | |
ethosuximide | Capsule | 250 mg | |
ethosuximide | Oral liquid | 250 mg/5 ml | |
phenobarbital | Oral liquid | 20 mg/5mL (0.4%) | |
phenobarbital | Tablet | 10 mg | |
phenobarbital | Tablet | 100 mg | |
phenobarbital | Tablet | 50 mg | |
phenytoin | Oral liquid | 125 mg/5 mL | |
phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
primidone | Tablet | 250 mg | |
valproic acid (sodium valproate) | Oral liquid | 250 mg/5 mL | |
valproic acid (sodium valproate) | Tablet | 250 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amitriptyline | Tablet | 25 mg (hydrochloride) | |
fluoxetine | Oral liquid | 20 mg/5 ml | |
fluoxetine | Solid oral dosage form | 20mg | |
imipramine chlorohydrate | Solid oral dosage form | 10mg | |
imipramine chlorohydrate | Tablet | 25mg | |
tranylcypromine | Tablet | 25 mg | |
trazodone | Injection | 50 mg (hydrochloride)/5 ml | |
trazodone | Tablet | 50 mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ergotamine + caffeine | Tablet | 1 mg (tartrate) + 100 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
lithium carbonate | Solid oral dosage form | 300 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amantadine | Capsule | 100 mg (sulfate or hydrochloride) | |
biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
biperiden | Tablet | 2 mg (hydrochloride) | |
levodopa + carbidopa | Tablet | 250 mg + 25 mg | |
trihexyphenidyl | Tablet | 2 mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
chlorpromazine | Oral Solution (drops) | 40 mg (hydrochloride)/mL | |
chlorpromazine | Tablet | 100 mg | |
chlorpromazine | Tablet | 25 mg (hydrochloride) | |
clozapine | Tablet | 100mg | |
clozapine | Tablet | 25mg | |
clozapine | Tablet | 50mg | |
haloperidol | Oral liquid | 2 mg/mL | |
haloperidol | Tablet | 10 mg | |
haloperidol | Tablet | 5 mg | |
levomepromazine | Injection | 25 mg | |
levomepromazine | Oral liquid | 4 mg/mL (0.4%) | |
levomepromazine | Tablet | 25-100 mg | |
pipothiazine | Injection | 25mg/ml | |
thioridazine | Tablet | 25 mg (hydrochloride) | |
thioridazine | Tablet (prolonged release) | 200 mg (hydrochloride) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ascorbic acid | Oral liquid | 100 mg/mL | |
ascorbic acid | Tablet | 500 mg | |
pyridoxine | Tablet | 50mg (chlorohydrate) | |
retinol | Capsule | 50 000 IU (as palmitate) | |
thiamine | Injection | 100mg (chlorohydrate)/ml | |
thiamine | Solid oral dosage form | 300 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dihydromorphone | Injection | 2.5 mg (hydrochloride)/ml | |
dihydromorphone | Tablet | 2.5 mg (hydrochloride) | |
meperidine | Injection | 100 mg (hydrochloride)/2 ml | |
morphine | Injection | 100 mg/2 mL | |
tramadol | Injection | 100 mg (hydrochloride)/2 mL | |
tramadol | Injection | 50 mg (hydrochloride)/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
dipyrone | Injection | 40-50% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
bupivacaine | Injection | 0.5% (hydrochloride) without preservant | |
bupivacaine | Injection | 0.5% / 1:200,000 (with epinephrine, without preservant) | |
droperidol | Injection | 2.5 mg/ml + 0.05 mg/ml fentanyl | |
enflurane | Inhalation (medicine gas) | N/A | |
fentanyl | Injection | 50 mcg (citrate)/mL | |
halothane | Inhalation | N/A | |
isoflurane | Inhalation | N/A | |
ketamine | Injection | 200 mg (hydrochloride)/20 mL | |
ketamine | Injection | 500 mg (hydrochloride)/10 mL | |
lidocaine | Injection | 5% (hydrochloride) + 7.5% dextrose | |
thiopental | Powder for injection | 1 g |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
midazolam | Injection | 1 mg/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
diazepam | Injection | 5 mg/mL | |
phenobarbital | Injection | 200 mg (sodium)/mL | |
phenobarbital | Injection | 200 mg/mL (sodium) | |
phenytoin | Injection | 250 mg (sodium)/5 mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
neostigmine | Injection | 500 mcg (methylsulfate) in 1-mL ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
pancuronium | Injection | 2 mg (bromuro)/mL | |
suxamethonium | Injection | 100mg/ml | |
tubocurarine | Injection | 0.3% (chloride) | |
vecuronium | Powder for injection | 10 mg (bromide)/mL in ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
chorionic gonadotropin (human) | Injection | 1000 IU/mL | |
chorionic gonadotropin (human) | Injection | 5000 IU/mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
conjugated estrogens | Powder for injection | 25 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ergometrine | Injection | 200 micrograms (hydrogen maleate) in 1-ml ampoule | |
oxytocin | Injection | 10 IU in 1-mL ampoule | |
oxytocin | Injection | 5 IU/mL | |
prostaglandin E | Vaginal tablet | 3 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amikacin | Injection | 100 mg (sulfate)/2 mL | |
amikacin | Injection | 500 mg (sulfate)/2 mL | |
amphotericin B | Powder for injection | 50 mg in vial | |
aztreonam | Powder for injection | 0.5 g | |
aztreonam | Powder for injection | 1 g | |
ceftriaxone | Injection | 1 g | |
ceftriaxone | Injection | 500 mg | |
chloramphenicol | Powder for injection | 1 g (sodium succinate) in vial | |
ciprofloxacin | Injection | 100 mg (hydrochloride)/10 ml | |
clindamycin | Injection | 15% (phosphate) | |
metronidazole | Injection | 5 mg/mL | |
oxacillin | Injection | 1g | |
praziquantel | Tablet | 600 mg | |
ticarcillin | Powder for injection | 3 g (sodium salt) | |
ticarcillin | Powder for injection | 6 g (sodium salt) |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amiodarone | Injection | 150 mg | |
atropine | Injection | 1 mg (sulfate) in 1-ml ampoule | |
digoxin | Injection | 0.2 mg (detamethyl)/2 mL | |
dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial | |
epinephrine (adrenaline) | Injection | 1 mg (hydrochloride)/mL | |
heparin sodium | Injection | 5000 IU/mL in 1-mL ampoule | |
lidocaine | Injection | 2% (hydrochloride) in vial | |
low molecular weight heparin | Injection | according to availability | |
mannitol | Injectable solution | 10% | |
mannitol | Injectable solution | 20% | |
procainamide | Injection | 100 mg (hydrochloride)/mL | |
propranolol | Injection | 1mg (hydrochloride)/ml | |
sodium nitroprusside | Powder for infusion | 50 mg in ampoule | |
streptokinase | Powder for injection | 1.5 million IU in vial | |
streptokinase | Powder for injection | 750,000 IU | |
verapamil | Injection | 2.5 mg (hydrochloride)/mL in 2-mL ampoule |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
amino acids | Injection | N/A | |
amino acids | Oral liquid | N/A |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
anti-D immunoglobulin (human) | Injection | 250-300 mcg/2 mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylcysteine | Inhalation | 10% | |
aminophylline | Injection | 240 mg/10 mL |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
calcium gluconate | Injection | 10% | |
glucose | Injection | 33% | |
glucose | Parenteral formulation | 10% | |
glucose | Parenteral formulation | 5% | |
glucose with sodium chloride | Injectable solution | 5% glucose, 0.9% sodium chloride (equivalent to 150 mmol/L Na+ and 150 mmol/L Cl-) | |
magnesium sulfate | Injection | 20% | |
potassium chloride | Injection | 20 mEq/10 ml | |
ringer lactate solution | Parenteral formulation | N/A | |
sodium bicarbonate | Injection | 10 mEq/10 mL | |
sodium chloride | Injection | 20 mEq/10 mL | |
sodium chloride | Parenteral formulation | 0.9% (100 mL) | |
sodium lactate, compound solution | Injectable solution | N/A | |
water for injection | Injection | 1-ml ampoules | |
water for injection | N/A | 10-ml ampoules | |
water for injection | N/A | 2-ml ampoules | |
water for injection | N/A | 5-mL ampoules |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
alpha chymotrypsin | Solution (eye drops) | 750 IU/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
absorbable sterile gel | Sponge | N/A | |
factor IX | Dried | 1000 IU | |
factor IX | Dried | 250 IU | |
factor IX | Dried | 500 IU | |
factor VIII concentrate | Dried | N/A | |
protamine sulfate | Injection | 10 mg/mL | |
tranexamic acid | Injection | 500 mg/5 ml | |
tranexamic acid | Tablet | 500 mg | |
vitamin K1 | Injection | 0.2% - 1% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
albumin | Injection | 20%-25% | |
plasma protein fraction | Injection | 100% (pure) | |
plasma protein fraction | Injection | no less than 4% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
low molecular weight dextran | Injection | 10% in 0.9% sodium chloride | |
low molecular weight dextran | Injection | 10% in dextrose |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
acetylcysteine | Injection | 300 mg/3 ml | |
ascorbic acid | Solution for injection | 100 mg/mL | |
calcium gluconate | Gel | 2.5% | |
charcoal, activated | Powder | N/A | |
deferoxamine | Powder for injection | 500 mg (mesilate) in vial | |
dimercaprol | Injection | 100 mg/mL | |
doxapram | Injection | 2% (hydrochloride) | |
edetate calcium disodium | Injection | 20% | |
ethyl alcohol (ethanol) | Injection | 96% | |
ipecacuanha | Oral liquid | 250 mg/5 ml (5%) | |
methadone | Tablet | 5mg | |
methamizole | Injection | 1g | |
methylthioninium chloride (methylene blue) | Injection | 10 mg/ml | |
naloxone | Injection | 400 mcg (hydrochloride) in 1-mL ampoule | |
obidoxime | Injection | 25% (chloride) | |
penicillamine | Solid oral dosage form | 250 mg | |
phentolamine | Powder for injection | 5 mg | |
physostigmine | Injection | 1 mg (salicylate)/mL | |
pralidoxime | Injection | 5% | |
sodium hyposulfite | Injection | 2.5 g/10 ml - 5 g/10 ml | |
sodium nitrite | Injection | 3% |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
asparaginase | Powder for injection | 10 000 IU in vial | |
azathioprine | Tablet | 50 mg | |
bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
busulfan | Tablet | 2 mg | |
calcium folinate | Injection | 50 mg/5 mL | |
calcium folinate | Tablet | 15 mg | |
carboplatin | Injection | 450 mg | |
chlorambucil | Tablet | 2 mg | |
cisplatin | Powder for injection | 50 mg in vial | |
citarabine | Injection | 100 mg | |
citarabine | Injection | 500 mg | |
cyclophosphamide | Powder for injection | 500 mg in vial | |
cyclophosphamide | Tablet | 50 mg | |
cyproterone | Tablet | 50mg (as acetate) | |
dacarbazine | Injection | 200 mg | |
doxorubicin | Powder for injection | 10 mg (hydrochloride) in vial | |
etoposide | Injection | 100 mg/5mL | |
fluorouracil | Injection | 500mg/10ml | |
interferon alpha 2B | Powder for injection | millions of IU | |
melphalan | Tablet | 2 mg | |
mercaptopurine | Tablet | 50 mg | |
methotrexate | Injection | 5 mg (sodium)/2 ml | |
methotrexate | Injection | 500mg (sodium) | |
methotrexate | Injection | 50mg (sodium) | |
methotrexate | Tablet | 2.5 mg (as sodium salt) | |
ondansetron | Injection | 8 mg/4 ml | |
ondansetron | Tablet | 8 mg | |
procarbazine | Capsule | 50 mg (as hydrochloride) | |
tamoxifen | Tablet | 10 mg (as citrate) | |
tamoxifen | Tablet | 20 mg (as citrate) | |
thioguanine | Solid oral dosage form | 40 mg | |
vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
vincristine | Powder for injection | 1 mg (sulfate) in vial |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
didanosine (ddI) | Tablet (buffered chewable, dispersible) | 100 mg | |
didanosine (ddI) | Tablet (buffered chewable, dispersible) | 25 mg | |
indinavir (IDV) | Capsule | 400mg | |
indinavir (IDV) | Solid oral dosage form | 200 mg | |
lamivudine (3TC) | Oral liquid | 10mg/ml | |
lamivudine (3TC) | Tablet | 150 mg | |
lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
nelfinavir | Oral liquid | 50 mg/ml | |
nelfinavir | Tablet | 250 mg | |
nevirapine (NVP) | Oral liquid | 50 mg/5 ml | |
nevirapine (NVP) | Tablet | 200 mg | |
pentamidine | Powder for injection | 200 mg (isetionate) in vial | |
pentamidine | Respirator solution for use in nebulizers | 5-10% (isethionate) | |
ritonavir | Oral liquid | 80 mg/ml | |
ritonavir | Solid oral dosage form | 100 mg | |
stavudine (d4T) | Capsule | 30 mg | |
stavudine (d4T) | Powder for oral administration | 1mg/ml | |
stavudine (d4T) | Solid oral dosage form | 40mg | |
sulfamethoxazole + trimethoprim | Injection | 400 mg + 80 mg/5 mL | |
zidovudine (ZDV or AZT) | Capsule | 100 mg | |
zidovudine (ZDV or AZT) | Injection | 10 mg/mL | |
zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL | |
zidovudine (ZDV or AZT) | Tablet | 300 mg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
cyclosporine | Capsule (softgel) | 100mg | |
cyclosporine | Capsule (softgel) | 25mg | |
cyclosporine | Capsule (softgel) | 50mg | |
cyclosporine | Injection | 50mg/ml | |
cyclosporine | Oral liquid | 100 mg/ml |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
hemodialysis solution | Parenteral formulation | N/A | |
intraperitoneal dialysis solution (of appropriate composition) | Parenteral solution | N/A | |
potassium resin exchangers | Enema | N/A | |
vitamin D | Capsule | 0.5 mcg | |
vitamin D | Tablet | 250mcg |
Medicamento | Forma farmacêutica | Composição | Observações |
---|---|---|---|
ampicillin + sulbactam | Powder for injection | 1 g (sodium) + 0.5 g (sodium) | |
dobutamine | Injection | 250 mg/20 mL | |
doxapram | Injection | 400 mg (hydrochloride)/20 ml | |
fluconazole | Injection | 200 mg/100 mL | |
glyceryl trinitrate | Injection | 0.5% | |
imipenem + cilastatin | Injection | 500mg + 500mg | |
levamisole | Tablet | 150 mg (as hydrochloride) | |
meropenem | Injection | 500 mg | |
meropenem | Powder for injection | 1 g | |
methylprednisolone | Injection | 500 mg (sodium succinate) | |
nimodipine | Injection | 10 mg/50 mL | |
vancomycin | Injection | 500 mg (chlorohydrate) |